Global CNS Therapeutics Strategic Report 2023: Market to Reach $199 Billion by 2030 - Developing Market to Drive the Market Momentum, Asia-Pacific to Exhibit Fastest Growth
November 30, 2023 05:38 ET
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global CNS Therapeutics Market to...
Rising Prevalence Fuels Growth: Diabetic Neuropathic Pain Market Set to Surge Through 2031
August 29, 2023 06:53 ET
|
Research and Markets
Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The "Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet...
US Neuropathic Pain Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales
May 31, 2021 08:08 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Neuropathic Pain Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Neuropathic Pain Market and...
Global Neuropathic Pain Epidemiology and Patient Flow Report 2021-2035
May 18, 2021 05:48 ET
|
Research and Markets
Dublin, May 18, 2021 (GLOBE NEWSWIRE) -- The "Global Neuropathic Pain Epidemiology and Patient Flow - 2021" report has been added to ResearchAndMarkets.com's offering. Global Neuropathic Pain...
Insights on the CNS Therapeutics Global Market to 2025 - Featuring AbbVie, Alkermes and Allergan Among Others
April 13, 2021 08:13 ET
|
Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The global market for CNS...